Literature DB >> 20546325

Migraine pain and nociceptor activation--where do we stand?

Dan Levy1.   

Abstract

The mechanisms underlying the genesis of migraine pain remain enigmatic largely because of the absence of any identifiable cephalic pathology. Based on numerous indirect lines of evidence, 2 nonmutually exclusive hypotheses have been put forward. The first theorizes that migraine pain originates in the periphery and requires the activation of primary afferent nociceptive neurons that innervate cephalic tissues, primarily the cranial meninges and their related blood vessels. The second maintains that nociceptor activation may not be required and that the headache is promoted primarily as a result of abnormal processing of sensory signals in the central nervous system. This paper reviews the evidence leading to these disparate theories while siding with the primacy of nociceptor activation in the genesis migraine headache. The paper further examines the potential future use of established human models of migraine for addressing the origin of migraine headache.

Entities:  

Mesh:

Year:  2010        PMID: 20546325     DOI: 10.1111/j.1526-4610.2010.01670.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  31 in total

1.  Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors.

Authors:  Xichun Zhang; Rami Burstein; Dan Levy
Journal:  Cephalalgia       Date:  2011-12-05       Impact factor: 6.292

2.  Non-invasive dural stimulation in mice: A novel preclinical model of migraine.

Authors:  Carolina Christina Burgos-Vega; Lilyana D Quigley; Gabriela Trevisan Dos Santos; Flora Yan; Marina Asiedu; Blaine Jacobs; Marina Motina; Nida Safdar; Hayyan Yousuf; Amanda Avona; Theodore John Price; Greg Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

Review 3.  Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.

Authors:  Osvaldo D Uchitel; Carlota González Inchauspe; Mariano N Di Guilmi
Journal:  Biophys Rev       Date:  2013-12-03

Review 4.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

Review 5.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

6.  The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.

Authors:  Mina Abdolahi; Abbas Tafakhori; Mansoureh Togha; Ali Asghar Okhovat; Feridoun Siassi; Mohammad Reza Eshraghian; Mohsen Sedighiyan; Mona Djalali; Niyaz Mohammadzadeh Honarvar; Mahmoud Djalali
Journal:  Immunogenetics       Date:  2017-05-06       Impact factor: 2.846

7.  Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms.

Authors:  Bianca N Mason; Eric A Kaiser; Adisa Kuburas; Maria-Cristina M Loomis; John A Latham; Leon F Garcia-Martinez; Andrew F Russo
Journal:  J Neurosci       Date:  2017-01-04       Impact factor: 6.167

Review 8.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

9.  Influence of sex, estrous cycle, and estrogen on intracranial dural mast cells.

Authors:  Tanner Boes; Dan Levy
Journal:  Cephalalgia       Date:  2012-07-24       Impact factor: 6.292

Review 10.  Ion channels and migraine.

Authors:  Jin Yan; Gregory Dussor
Journal:  Headache       Date:  2014-04       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.